Dr. Griffin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
6500 Harris Pkwy
Fort Worth, TX 76132Phone+1 817-263-2600- Is this information wrong?
Education & Training
- University of South Florida MorsaniFellowship, Hematology and Medical Oncology, 2013 - 2016
- University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Internal Medicine, 2010 - 2013
- McGovern Medical School at UTHealthClass of 2010
Certifications & Licensure
- TX State Medical License 2015 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Abstract Achievement Award American Society of Hematology 56th Annual Meeting, 2014
- Doctor's Dilemma Champion Texas Chapter of the American College of Physicians Annual Meeting, 2012
- Abstract Achievement Award American Society of Hematology 53th Annual Meeting, 2011
- Join now to see all
Publications & Presentations
PubMed
- 10 citationsBone marrow cellularity at day 14 is the most important predictive factor for response in patients with AML who require double-induction chemotherapy: Analysis from a ...Patrick T. Griffin, Rami S. Komrokji, Kendra Sweet, Najla Al Ali, Eric Padron, Timothy E. Kubal, Alan F. List, Jeffrey E. Lancet> ;American Journal of Hematology. 2017 Mar 1
- AOHE: manuscript AOHE-D-16-00564 paroxysmal nocturnal hemoglobinuria with autoimmune hemolytic anemia following eculizumab therapy-with large granular lymphocytic leuk...Nathan Visweshwar, Michael Jaglal, Cassie Booth, Patrick T. Griffin, Damian A. Laber> ;Annals of Hematology. 2016 Jul 23
- 37 citationsA comparison of salvage infusional chemotherapy regimens for recurrent/refractory multiple myelomaPatrick T. Griffin, Viet Q. Ho, William J. Fulp, Taiga Nishihori, Kenneth H. Shain, Melissa Alsina, Rachid Baz> ;Cancer. 2015 Oct 15
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Increased Treatment Intensity Is Not Associated with a Survival Benefit in Patients with Low and Intermediate Risk Mantle Cell Lymphoma, Retrospective AnalysisGriffin PT, Chavez JC, Bello CM, et al., American Society of Hematology 56th Annual Meeting, San Francisco, CA, 12/2014
- Multivariate Survival Analysis of Transformed Lymphoma in the Chemoimmunotherapy Era: Impact of the NCCN International Prognostic IndexGriffin PT, Dalia S, Shah BD, et al., American Society of Hematology 56th Annual Meeting, San Francisco, CA, 12/2014
- Is There a Preferred Infusional Regimen for Patients with Relapsed/Refractory Multiple Myeloma?Griffin PT, Ho VQ, Fulp W, et al, American Society of Hematology 56th Annual Meeting, San Francisco, CA, 12/2014
- Join now to see all
Press Mentions
- In Brief: Medline Acquisition, BOC Honor, Brightree IntegrationMay 21st, 2021
Professional Memberships
- Member
- Member
- Member
- Member
- Member
Hospital Affiliations
- Texas Health Harris Methodist Hospital Southwest Fort WorthFort Worth, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: